# Clustering Approach 1 : CN_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.646435307698857	Range of duration = 0.03 to 26.99, nDeath = 5, nCensor = 17
2	AGE	ANOVA	0.588874382865424	Range of values = 24 to 90, Mean = 61.0769, StdDev = 15.3204, nMissing = 3
3	PRIMARY.SITE.OF.DISEASE	Chi-square test	0.23010100390503	nTypes = 3 (DISTANT METASTASIS/PRIMARY TUMOR/REGIONAL CUTANEOUS OR SUBCUTANEOUS TISSUE (INCLUDES SATELLITE AND IN-TRANSIT METASTASIS)), nPatients = 2/25/2
4	GENDER	Fisher's exact test	0.278283934955603	nTypes = 2 (FEMALE/MALE), nPatients = 9/20
5	LYMPH.NODE.METASTASIS	Chi-square test	0.594839039822776	nTypes = 8 (N0/N1A/N1B/N2A/N2B/N2C/N3/NX), nPatients = 15/1/1/1/3/1/3/3, nMissing = 1
6	TUMOR.STAGECODE	ANOVA	NA	Range of values = Inf to -Inf, Mean = NaN, StdDev = NA, nMissing = 29
7	NEOPLASM.DISEASESTAGE	Chi-square test	0.602469790695783	nTypes = 8 (STAGE IB/STAGE II/STAGE IIA/STAGE IIC/STAGE IIIA/STAGE IIIB/STAGE IIIC/STAGE IV), nPatients = 1/1/1/15/1/3/4/1, nMissing = 2
